CollPlant Biotechnologies Ltd (OPHI) revenue by segment
OPHINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as CLGN
$3.40−0.20 (-5.56%)
Close on Nov 18, 2026Market cap $4.91MP/E –Yield –
CollPlant Biotechnologies Ltd revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues from milestones | $2.00M | – | $10.00M | – | – | – | – | – | 84.4% | – |
| Revenues from the Sales of Goods | $371.00K | $515.00K | $959.00K | $299.00K | $1.60M | – | – | – | 15.6% | -28.0% |
| Revenues from licensing agreement | – | – | $10.00M | – | $14.00M | – | – | – | – | – |
| Revenues from the rendering of services | – | – | – | – | $46.00K | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | $2.18M | $484.00K | $10.84M | $16.00K | $14.95M | $5.77M | $2.08M | $4.87M | 91.8% | +349.6% |
| Europe and others | $98.00K | – | $28.00K | $104.00K | $633.00K | $369.00K | $240.00K | – | 4.1% | – |
| Canada | $96.00K | – | $87.00K | $158.00K | $57.00K | – | – | – | 4.0% | – |
| Israel | $1.00K | $31.00K | $5.00K | $21.00K | – | – | – | – | 0.0% | -96.8% |
| Total | – | – | – | $299.00K | $15.64M | $6.14M | $2.32M | $5.01M | – | – |
From the segment and revenue-disaggregation notes of CollPlant Biotechnologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes. The KPIs tab shows these segments next to CollPlant Biotechnologies's operating metrics, with full history, charts and a link to each filing.
See a number that looks wrong?